In a blistering month for stocks, Aphria has had a particularly bumpy ride.
The Leamington, Canada-based cannabis company was the target of some explosive (and, as we'll see, spurious) allegations from, as it turns out, a firm with substantial short interest. This is a common enough occurrence in the stock market, as Carl Icahn and Bill Ackman's legendary "long vs. short" battle royale over Herbalife Nutrition illustrates.
The short-seller's allegations focus only on Aphria and one other, small company: Toronto, Ont.-based SOL Global Investments. They have nothing to do with other cannabis firms we follow at the National Institute for Cannabis Investors
But, since the short attack and furious price action last week, I wanted everyone to know what's really happening with Aphria.
It's the truth you won't hear anywhere else – and, even better, a beautifully wrapped-up December buying opportunity...